Cleared Special

K130806 - NEUROVISION INK PRINTED ENDOTRACHEAL TUBE ELECTRODE (FDA 510(k) Clearance)

Class II Neurology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
109d
Days
Class 2
Risk

K130806 is an FDA 510(k) clearance for the NEUROVISION INK PRINTED ENDOTRACHEAL TUBE ELECTRODE. Classified as Neurosurgical Nerve Locator (product code PDQ), Class II - Special Controls.

Submitted by Neurovision Medical Products, Inc. (Ventura, US). The FDA issued a Cleared decision on July 12, 2013 after a review of 109 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 874.1820 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Neurovision Medical Products, Inc. devices

Submission Details

510(k) Number K130806 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 2013
Decision Date July 12, 2013
Days to Decision 109 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 148d · This submission: 109d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code PDQ Neurosurgical Nerve Locator
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 874.1820
Definition To Locate Or Monitor Function Of Spinal Nerve Roots Or Peripheral Nerves During Neurosurgery.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - PDQ Neurosurgical Nerve Locator

All 34
Devices cleared under the same product code (PDQ) and FDA review panel - the closest regulatory comparables to K130806.
Sterile Insulated Dilators, 5, 10, 16mm (MDT-0442S)
K253580 · Tedan Surgical Innovations · Apr 2026
Neuralytix iD3 System (NTX-9001)
K243636 · Neuralytix, LLC · Jun 2025
TELIGEN System Peripheral Motor Nerve Stimulation Indications
K223438 · Medos International SARL · Feb 2023
ATEC IOM Accessory Instruments
K221821 · Alphatec Spine, Inc. · Sep 2022
PediGuard Threaded
K220160 · Spineguard S.A. · Mar 2022
Neurosign V4 Intraoperative Nerve Monitor
K203684 · Magstim Company, Ltd. · Mar 2021